Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
NCT00672139
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
156
Enrollment
INDUSTRY
Sponsor class
Conditions
Opioid-Induced Constipation
Interventions
DRUG:
Methylnaltrexone bromide
Sponsor
Bausch Health Americas, Inc.
Collaborators
[object Object]